Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De Novo Q2W Darbepoetin Alfa in CKD
NCT00112008Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2004
- Primary completion
- Mar 2005
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started May 2004; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00112008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112008.